Brief: Vigil Neuroscience Q3 EPS USD -0.53
07/11/2023 12:05
Nov 07 (Reuters) - Vigil Neuroscience Q3 operating expenses USD 22.321 million. * Q3 operating income USD -22.321 million * Q3 net income USD -20.495 million
Recent news on Vigil Neuroscience
See all newsVigil Neuroscience Inc reports results for the quarter ended June 30 - Earnings Summary
Vigil Neuroscience Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
U.S. RESEARCH ROUNDUP-Ralph Lauren, Vigil Neuroscience, Workday
Deals of the day-Mergers and acquisitions